About Asa Rén
Asa Rén is a Healthcare company based in Jakarta (Indonesia) founded in 2020. AI-powered platform for precision medicine and longevity research is developed. Asa Rén has raised $8.15 million across 1 funding round from investors including Diagnos Laboratorium Utama, Top Harvest Capital and Kejora Capital. Its website asaren.ai draws about 41 thousand monthly visits. Asa Rén offers products and services including AsaX App and AI-assisted Platform. Its focus areas include HealthTech, Healthcare Booking Platforms, Diagnostics and Internet First Clinical Labs. Its legal entity is Asa Ren Pte Ltd. Its competitors include DNAandMe and BioElitics.
Company details
Founded in 2020 and based in Jakarta, Indonesia, an AI-powered platform is developed by Asa Rén for precision medicine and longevity research. Services are provided to healthcare providers, synthetic life and data science entities, and individuals. Personalized treatments are advanced, treatment and medicine performance is predicted, and life-saving technologies are discovered. Impact is created across health segments to support a unified ecosystem in the healthcare sector.
- Total Equity Funding$8.15M (USD)
in 1 rounds
- Latest Funding Round$8.15M (USD), Seed
Feb 2023
- InvestorsDiagnos Laboratorium Utama
& 5 more
Products & Services of Asa Rén
Asa Rén offers a comprehensive portfolio of products and services, including AsaX App and AI-assisted Platform.
App for personalized healthcare using clinico-genomic data and real-time insights.
Platform for health data analysis and personalized treatment recommendations.
Apps and channels of Asa Rén
Asa Rén publishes 2 mobile apps with over 1K+ downloads; its YouTube channel Asaren Experience has 612 subscribers and 27 videos.
Videos from Asa Rén
The most watched videos on Asa Rén's YouTube channel, Asaren Experience (612 subscribers). Click a video to play it here.
More on Asaren Experience.
Funding Insights of Asa Rén
Asa Rén has successfully raised a total of $8.15M through 1 strategic funding round. The most recent funding activity was a Seed round of $8.15 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.15M
- Total Rounds 1
- Last Round Seed — $8.15M
- First Round $8.15M
(Feb 2023)
- Investors Count 6
All 1 funding rounds of Asa Rén with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | $8.15M | Seed | – | Top Harvest Capital, Kejora Capital |
6 investors in total: 6 institutional.
Investors in Asa Rén
Asa Rén has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Diagnos Laboratorium Utama, Top Harvest Capital and Kejora Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| topharvestcap.com | ||||
| kejorahq.com | ||||
Venture capital firm investing in consumer businesses | marcyvp.com | San Francisco, United States | ||
Venture capital firm focused on early-stage investments | nsgroup.com | Singapore, Singapore | ||
Diagnostic test kits are manufactured for healthcare applications in Indonesia. | 2017 | diagnos.co.id | Jakarta, Indonesia | |
Manages concentrated global equity portfolios using fundamental analysis for professional clients. | 2012 | nayacapital.com | London, United Kingdom |
Investor details for Asa Rén
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Asa Rén
2 dated milestones of Asa Rén across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Asa Rén is founded.
- Funding First funding round of $8.2M.
Competitors of Asa Rén
Asa Rén has 2 listed competitors in our database. They include DNAandMe and BioElitics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dnaandme.id | 2022 | Jakarta, Indonesia | Provides genetic testing for diet, health risks, and personal traits analysis. | |||
| bioelitics.com | 2014 | Dumai, Indonesia | Provides DNA analysis services to identify hereditary diseases. |
Detailed competitors of Asa Rén
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Asa Rén
The website of Asa Rén (asaren.ai) receives about 41K visits a month.
- Monthly visits41K
▲ 2919.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Asa Rén
Complete news archive for Asa Rén
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asa Rén
Asa Rén was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Asa Rén is headquartered in Jakarta, Indonesia. It is registered at Jakarta, Jakarta, Indonesia.
Asa Rén is a funded company, having raised a total of $8.15M across 1 funding round to date. The company's 1st funding round was a Seed of $8.15M, raised on Feb 2023.
Founded in 2020 and based in Jakarta, Indonesia, an AI-powered platform is developed by Asa Rén for precision medicine and longevity research. Services are provided to healthcare providers, synthetic life and data science entities, and individuals. Personalized treatments are advanced, treatment and medicine performance is predicted, and life-saving technologies are discovered. Impact is created across health segments to support a unified ecosystem in the healthcare sector.
Asa Rén's top competitors include DNAandMe and BioElitics.
Asa Rén offers AsaX App and AI-assisted Platform.
Asa Rén has 6 investors. Key investors include Diagnos Laboratorium Utama, Top Harvest Capital, Kejora Capital, Marcy Venture Partners, and Northstar Group.
Asa Rén operates through Asa Ren Pte Ltd.
Yes. Asa Rén publishes Asa Ren and 1 more app, with over 1,000 downloads.